305 related articles for article (PubMed ID: 32761647)
1. Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?
Gouda AS; Mégarbane B
Drug Dev Res; 2021 Feb; 82(1):38-48. PubMed ID: 32761647
[TBL] [Abstract][Full Text] [Related]
2. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Nicolau LAD; Magalhães PJC; Vale ML
Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
4. Potential Implications of Angiotensin-converting Enzyme 2 Blockades on Neuroinflammation in SARS-CoV-2 Infection.
Paul D; Mohankumar SK; Thomas RS; Kheng CB; Basavan D
Curr Drug Targets; 2022; 23(4):364-372. PubMed ID: 34732115
[TBL] [Abstract][Full Text] [Related]
5. Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.
Cooper SL; Boyle E; Jefferson SR; Heslop CRA; Mohan P; Mohanraj GGJ; Sidow HA; Tan RCP; Hill SJ; Woolard J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361021
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Bradykinin: Mystery in the Pathogenesis of COVID-19.
Tabassum A; Iqbal MS; Sultan S; Alhuthali RA; Alshubaili DI; Sayyam RS; Abyad LM; Qasem AH; Arbaeen AF
Mediators Inflamm; 2022; 2022():7423537. PubMed ID: 35153624
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology.
Sohaei D; Hollenberg M; Janket SJ; Diamandis EP; Poda G; Prassas I
Crit Rev Clin Lab Sci; 2023 Jan; 60(1):25-40. PubMed ID: 35930434
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Hu Y; Liu L; Lu X
Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
Shukla AK; Banerjee M
High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme 2 at the interface between renin-angiotensin system inhibition and coronavirus disease 2019.
Siri-Angkul N; Chattipakorn SC; Chattipakorn N
J Physiol; 2020 Oct; 598(19):4181-4195. PubMed ID: 32710575
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients.
Gouda AS; Adbelruhman FG; Elbendary RN; Alharbi FA; Alhamrani SQ; Mégarbane B
Saudi J Biol Sci; 2021 Jun; 28(6):3540-3547. PubMed ID: 33746538
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial.
Mansour E; Bueno FF; de Lima-Júnior JC; Palma A; Monfort-Pires M; Bombassaro B; Araujo EP; Bernardes AF; Ulaf RG; Nunes TA; Ribeiro LC; Falcão ALE; Santos TM; Trabasso P; Dertkigil RP; Dertkigil SS; Maia RP; Benaglia T; Moretti ML; Velloso LA
Trials; 2021 Jan; 22(1):71. PubMed ID: 33472675
[TBL] [Abstract][Full Text] [Related]
15. Hypertension, a Moving Target in COVID-19: Current Views and Perspectives.
Savoia C; Volpe M; Kreutz R
Circ Res; 2021 Apr; 128(7):1062-1079. PubMed ID: 33793331
[TBL] [Abstract][Full Text] [Related]
16. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients.
Soltani Hekmat A; Javanmardi K
J Renin Angiotensin Aldosterone Syst; 2021; 2021():6824259. PubMed ID: 34853605
[TBL] [Abstract][Full Text] [Related]
17. [Role of ACE2 in COVID-19].
Imai Y
Nihon Yakurigaku Zasshi; 2022; 157(2):115-118. PubMed ID: 35228442
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system at the interface of COVID-19 infection.
Gul R; Kim UH; Alfadda AA
Eur J Pharmacol; 2021 Jan; 890():173656. PubMed ID: 33086029
[TBL] [Abstract][Full Text] [Related]
19. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
